132 related articles for article (PubMed ID: 1154189)
1. Cryoprecipitate.
Armstrong D
S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189
[No Abstract] [Full Text] [Related]
2. A hemophilia home care program utilizing cryoprecipitate.
Shanberge JN; Kratz NL; Aster RH
Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309
[No Abstract] [Full Text] [Related]
3. Jaundice and hepatitis B antigen-antibody in hemophilia.
Lewis JH; Maxwell NG; Brandon JM
Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949
[No Abstract] [Full Text] [Related]
4. Factor VIII concentrates made in the United Kingdom and the treatment of haemophilia based on studies made during 1969--72. Report of the Medical Research Council's Blood Transfusion Research Committee Working Party on the cryoprecipitate method of preparing AHF concentrates.
Br J Haematol; 1974 Jul; 27(3):391-405. PubMed ID: 4413414
[No Abstract] [Full Text] [Related]
5. The preparation of cryoprecipitate in a mobile laboratory: A five-year experience.
Keating LJ
Transfusion; 1974; 14(3):283-6. PubMed ID: 4835954
[No Abstract] [Full Text] [Related]
6. Therapy for AHF and PTC hemophilia. I.
Seeler RA
IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774
[No Abstract] [Full Text] [Related]
7. Letter: Use and misuse of cryoprecipitate.
Hensley MJ
N Engl J Med; 1975 Jun; 292(24):1299. PubMed ID: 1128599
[No Abstract] [Full Text] [Related]
8. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
Otto-Servais M; Hugues J
Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
[No Abstract] [Full Text] [Related]
9. Developments and problems in the management of hemophilia.
Jones P
Semin Hematol; 1977 Oct; 14(4):375-90. PubMed ID: 335521
[No Abstract] [Full Text] [Related]
10. [Hemophilia: the blood bank's concern?].
Smit Sibinga CT
Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
[No Abstract] [Full Text] [Related]
11. [Therapy-induced hepatitis risk in hemophilia patients].
Schiller WG; Renger FG
Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
[No Abstract] [Full Text] [Related]
12. Development of large-scale fractionation methods. 3. Preparation of a factor VIII concentrate of intermediate-purity.
James HL; Wickerhauser M
Vox Sang; 1972; 23(5):402-12. PubMed ID: 5077739
[No Abstract] [Full Text] [Related]
13. A simple and inexpensive device for pooling cryoprecipitate.
Low WT; Gillon R; Jones P
Lancet; 1977 Sep; 2(8039):641. PubMed ID: 71453
[No Abstract] [Full Text] [Related]
14. [Efficacy of factor 8 rich cryoproteins in the treatment of hemophilia].
Vergoz D; Combrisson A; Vialette T; André R
Transfusion (Paris); 1967; 10(1):3-10. PubMed ID: 6048649
[No Abstract] [Full Text] [Related]
15. Antihaemophilic cryoprecipitate from fresh plasma and its use in haemophilia.
Brüster H; Glassner K; Riech PC
Ger Med Mon; 1968 Mar; 13(3):129-33. PubMed ID: 5656869
[No Abstract] [Full Text] [Related]
16. Dose requirement for replacement therapy in hemophilia A.
Allain JP
Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
[TBL] [Abstract][Full Text] [Related]
17. Cryoprecipitate--a new product for the control of bleeding in haemophilic patients.
Grobbelaar BG; Clyde JH; Seimon L
S Afr Med J; 1967 Feb; 41(5):91-2. PubMed ID: 6021085
[No Abstract] [Full Text] [Related]
18. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.
Schimpf K; Mannucci PM; Kreutz W; Brackmann HH; Auerswald G; Ciavarella N; Mösseler J; DeRosa V; Kraus B; Brueckmann C
N Engl J Med; 1987 Apr; 316(15):918-22. PubMed ID: 3102963
[TBL] [Abstract][Full Text] [Related]
19. [Tooth extraction during substitution treatment in hemophilia A and B--Report of experiences with the use of cryoprecipitate and Cohn plasma fractions I and of contact activating fresh plasma].
Hausamen JE; Brüster HT; Riech P; Pape HD; Neumann D
Dtsch Zahnarztl Z; 1970 Feb; 25(2):319-25. PubMed ID: 5309299
[No Abstract] [Full Text] [Related]
20. [Late haemolytic complications following antihaemophilic plasma and antihaemophilic kryoprotein (author's transl)].
Filová A; Hrubisková K; Busová B
Bratisl Lek Listy; 1977 Oct; 68(4):456-61. PubMed ID: 922523
[No Abstract] [Full Text] [Related]
[Next] [New Search]
